Why the study?
Cardiovascular complications such as myocarditis are linked to both COVID-19 infection and mRNA COVID-19 vaccines, causing public hesitancy regarding vaccine safety.
Do COVID-19 viral infection and its mRNA vaccine carry an equivalent risk of myocarditis?
Do COVID-19 viral infection and its mRNA vaccine carry an equivalent risk of myocarditis?
This review clarifies the differing pathophysiological mechanisms of myocarditis induced by COVID-19 infection versus mRNA vaccines to help dispel vaccine hesitancy.
Answers are grounded in this paper and cite their sources.
Supports distinct myocarditis pathways by etiology; hypothesis-generating for differential risk counseling pending prospective data.
. Although therapeutic strategies such as antivirals, intravenous immunoglobulins and corticosteroids have shown modest efficacy in reducing the disease progression, they are not disease specific and only temper the immune mediated attack on the systemic tissues. Therefore, clinicians started to rely on mRNA COVID-19 vaccines, which are clinically efficacious in reducing the incidence, disease severity and systemic complications of COVID-19 infections. Nevertheless, usage of COVID-19 mRNA vaccines is also associated with cardiovascular complications such as myocarditis and pericarditis. On the other hand, COVID-19 infections itself are associated with cardiovascular complications such as myocarditis. The underlying signaling pathways for occurrence of COVID-19 and mRNA COVID-19 vaccine induced myocarditis are quite different although there is some overlap in autoimmunity and cross reactivity mechanisms. With media reports highlighting the cardiovascular complications of COVID-19 vaccines such as myocarditis, general population have become more hesitant and uncertain regarding the safety and efficacy of these mRNA vaccines. We plan to review the current literature and provide insights into their pathophysiological mechanisms for myocarditis and offer recommendations for further research studies in this regard. This will hopefully dispel some doubts and encourage more people to be vaccinated for preventing the risk of COVID-19 induced myocarditis and other associated cardiovascular complications.
No takes yet. Share an insight, caveat, or question.
Ulucay et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: